Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Non-Randomized, Sequentially Enrolled, Multi-Center, Phase II Study to Evaluate the SENSE Device's Ability to Detect and Monitor Traumatic Brain Injury

NCT05155800 is registered in ClinicalTrials.gov with Sense Diagnostics, LLC as lead sponsor.

NCT NCT05155800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05155800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Non-Randomized, Sequentially Enrolled, Multi-Center, Phase II Study to Evaluate the SENSE Device's Ability to Detect and Monitor Traumatic Brain Injury
Lead sponsor
Sense Diagnostics, LLC
Phase
Observational
Overall status
Completed
Start date
December 28, 2021
Completion date
November 15, 2023
Enrollment
75 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

traumatic brain injury